Short-term effects of positive end-expiratory pressure titration strategies on lung clinical markers in COVID-19: A randomized controlled trial.

Short-term effects of positive end-expiratory pressure titration strategies on lung clinical markers in COVID-19: A randomized controlled trial.

Publication date: Dec 08, 2025

Severe acute respiratory failure from COVID-19 is associated with high mortality. Optimal positive end-expiratory pressure (PEEP) titration is essential for lung-protective ventilation; however, different strategies may elicit distinct clinical responses. To compare the short-term effects of three PEEP titration strategies on lung injury score (LIS), changes in oxygenation, respiratory mechanics, and electrical impedance tomography (EIT) measures in mechanically ventilated patients with COVID-19. In this randomized, parallel-group trial, 75 intubated patients were randomly assigned to EIT-guided PEEP (PEEP-EIT), driving pressure-guided PEEP (PEEP-DP), or ARDSNet-based PEEP (PEEP-ARDSNet). Primary outcome was change in lung injury score (LIS); secondary outcomes included PaO₂/FiO₂ ≥ 150 mmHg, PaO₂/FiO₂ response ≥ 20 mmHg, driving pressure reduction, compliance increase, EIT-based regional ventilation and aeration, and adverse events within a four-hour follow-up. Mean PEEP levels differed across groups: PEEP-EIT (13. 3 cmH₂O), PEEP-DP (10. 6 cmH₂O), and ARDSNet (12 cmH₂O). PEEP-EIT showed greater LIS reduction (OR 3. 7, 1. 58 – 8. 57; p = 0. 004) and higher odds of oxygenation response vs. PEEP-DP (OR 4. 2, 2. 15 – 8. 27; p

Concepts Keywords
Driving COVID-19
Hour Electrical impedance
Lung Mechanical ventilation
Outperformed Respiratory mechanics
Tomography

Semantics

Type Source Name
disease MESH COVID-19
disease MESH lung injury
disease MESH included

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *